{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:57:20Z","timestamp":1793383040503,"version":"4.5.0"},"reference-count":132,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:00:00Z","timestamp":1760227200000},"content-version":"am","delay-in-days":345,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.bmc.2024.117939","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T14:56:04Z","timestamp":1728140164000},"page":"117939","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Digoxin and its Na+\/K+-ATPase-targeted actions on cardiovascular diseases and cancer"],"prefix":"10.1016","volume":"114","author":[{"given":"Yulin","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn M.","family":"Lauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith C.","family":"Gallucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Douglas Kinghorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2024.117939_b0005","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1002\/(SICI)1521-3773(19980918)37:17<2320::AID-ANIE2320>3.0.CO;2-2","article-title":"The identification of the sodium-potassium pump (Nobel lecture)","volume":"37","author":"Skou","year":"1998","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.bmc.2024.117939_b0010","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1016\/S0006-3495(01)76191-7","article-title":"Structure of Na+, K+-ATPase at 11-\u00c5 resolution: comparison with Ca2+-ATPase in E1 and E2 states","volume":"80","author":"Rice","year":"2001","journal-title":"Biophys J"},{"key":"10.1016\/j.bmc.2024.117939_b0015","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.str.2011.10.016","article-title":"First crystal structures of Na+, K+-ATPase: new light on the oldest ion pump","volume":"19","author":"Toyoshima","year":"2011","journal-title":"Structure"},{"key":"10.1016\/j.bmc.2024.117939_b0020","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nrm3031","article-title":"A structural overview of the plasma membrane Na+, K+-ATPase and H+-ATPase ion pumps","volume":"12","author":"Morth","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bmc.2024.117939_b0025","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3389\/fphys.2017.00371","article-title":"The structure and function of the Na, K-ATPase isoforms in health and disease","volume":"8","author":"Clausen","year":"2017","journal-title":"Front Physiol"},{"key":"10.1016\/j.bmc.2024.117939_b0030","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1038\/ncomms8622","article-title":"Mechanism of potassium ion uptake by the Na+\/K+-ATPase","volume":"6","author":"Castillo","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.bmc.2024.117939_b0035","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1152\/physiol.00008.2008","article-title":"The Na-K-ATPase and calcium-signaling microdomains","volume":"23","author":"Tian","year":"2008","journal-title":"Physiology"},{"key":"10.1016\/j.bmc.2024.117939_b0040","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00018-012-1039-9","article-title":"Na+, K+-ATPase as a docking station: protein-protein complexes of the Na+, K+-ATPase","volume":"70","author":"Reinhard","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.bmc.2024.117939_b0045","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3390\/molecules22060990","article-title":"Protein interaction and Na\/K-ATPase-mediated signal transduction","volume":"22","author":"Cui","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2024.117939_b0050","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bpj.2020.06.006","article-title":"Transient electrical currents mediated by the Na+\/K+-ATPase: a tour from basic biophysics to human diseases","volume":"119","author":"Moreno","year":"2020","journal-title":"Biophys J"},{"key":"10.1016\/j.bmc.2024.117939_b0055","first-page":"250","article-title":"Digitalis and the Na+, K+-ATPase","volume":"2","author":"Medford","year":"1993","journal-title":"Heart Dis Stroke"},{"key":"10.1016\/j.bmc.2024.117939_b0060","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.1074\/jbc.M112.442137","article-title":"A Structural view on the functional importance of the sugar moiety and steroid hydroxyls of cardiotonic steroids in binding to Na, K-ATPase","volume":"288","author":"Cornelius","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmc.2024.117939_b0065","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.biopha.2016.10.030","article-title":"Plant-derived cardiac glycosides: role in heart ailments and cancer management","volume":"84","author":"Patel","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmc.2024.117939_b0070","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.3390\/ijms19082336","article-title":"Na\/K-ATPase signaling and cardiac pre\/postconditioning with cardiotonic steroids","volume":"19","author":"Marck","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2024.117939_b0075","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1124\/mi.8.1.8","article-title":"Cardiac glycosides as novel cancer therapeutic agents","volume":"8","author":"Newman","year":"2008","journal-title":"Mol Intervent"},{"key":"10.1016\/j.bmc.2024.117939_b0080","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3390\/toxins13050344","article-title":"Quo vadis cardiac glycoside research?","volume":"13","author":"Bej\u010dek","year":"2021","journal-title":"Toxins"},{"key":"10.1016\/j.bmc.2024.117939_b0085","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.827334","article-title":"Regulation of cardiac contractility by the alpha 2 subunit of the Na+\/K+-ATPase","volume":"13","author":"Skogestad","year":"2022","journal-title":"Front Physiol"},{"key":"10.1016\/j.bmc.2024.117939_b0090","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1113\/JP283082","article-title":"Changes in cellular Ca2+ and Na+ regulation during the progression towards heart failure","volume":"601","author":"MacLeod","year":"2023","journal-title":"J Physiol"},{"key":"10.1016\/j.bmc.2024.117939_b0095","article-title":"The Na+\/K+-ATPase: a potential therapeutic target in cardiometabolic diseases","volume":"14:1150171","author":"Obradovic","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.bmc.2024.117939_b0100","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.3390\/ijms21041256","article-title":"The redox-sensitive Na\/K-ATPase signaling in uremic cardiomyopathy","volume":"21","author":"Liu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2024.117939_b0105","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1042\/CS20220796","article-title":"The vascular Na, K-ATPase: clinical implications in stroke, migraine, and hypertension","volume":"137","author":"Staehr","year":"2023","journal-title":"Clin Sci"},{"key":"10.1016\/j.bmc.2024.117939_b0110","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/eurheartj\/ehae105","article-title":"Heart failure pharmacotherapy and cancer: pathways and pre-clinical\/clinical evidence","volume":"45","author":"Sayour","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.bmc.2024.117939_b0115","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1517\/14728222.12.11.1403","article-title":"Na+\/K+-ATPase \u03b1 subunits as new targets in anticancer therapy","volume":"12","author":"Mijatovic","year":"2008","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.bmc.2024.117939_b0120","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1016\/j.bbadis.2018.09.014","article-title":"Crosstalk between Na+, K+-ATPase and a volume-regulated anion channel in membrane microdomains of human cancer cells","volume":"1864","author":"Fujii","year":"2018","journal-title":"BBA Mol Basis Dis"},{"key":"10.1016\/j.bmc.2024.117939_b0125","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.3390\/molecules25163596","article-title":"Anticancer and antiviral properties of cardiac glycosides: a review to explore the mechanism of actions","volume":"25","author":"Reddy","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2024.117939_b0130","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.3390\/cells10123341","article-title":"Cardiac glycosides as autophagy modulators","volume":"10","author":"\u0160kubn\u00edk","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bmc.2024.117939_b0135","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1007\/s00018-023-04910-9","article-title":"The mechanistic role of cardiac glycosides in DNA damage response and repair signaling","volume":"80","author":"Ainembabazi","year":"2023","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.bmc.2024.117939_b0140","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1039\/JR9300000508","article-title":"Digoxin, a new digitalis glucoside","author":"Smith","year":"1930","journal-title":"J Chem Soc"},{"key":"10.1016\/j.bmc.2024.117939_b0145","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0008-6215(92)84033-O","article-title":"The conformational behavior of the cardiac glycoside digoxin as indicated by NMR spectroscopy and molecular dynamics calculations","volume":"230","author":"Aulabaugh","year":"1992","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.bmc.2024.117939_b0150","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1107\/S0567740880007297","article-title":"Structure of digoxin","volume":"B36","author":"Go","year":"1980","journal-title":"Acta Cryst"},{"key":"10.1016\/j.bmc.2024.117939_b0155","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1021\/acs.jnatprod.6b00924","article-title":"Cardiac glycoside constituents of Streblus asper with potential antineoplastic activity","volume":"80","author":"Ren","year":"2017","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2024.117939_b0160","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1107\/S0021889812029111","article-title":"WinGX and ORTEP for windows: an update","volume":"45","author":"Farrugia","year":"2012","journal-title":"J Appl Cryst"},{"key":"10.1016\/j.bmc.2024.117939_b0165","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1016\/S0040-4039(01)81912-2","article-title":"14\u03b2-Hydroxy steroids. III. Synthesis of digoxigenin from deoxycholic acid","volume":"22","author":"Welzel","year":"1981","journal-title":"Tetrahedron Lett"},{"key":"10.1016\/j.bmc.2024.117939_b0170","doi-asserted-by":"crossref","first-page":"12105","DOI":"10.1021\/acs.joc.3c01067","article-title":"A short route to the synthesis of digoxose trisaccharide glycal donor via Mislow-Evans rearrangement","volume":"88","author":"Ali","year":"2023","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmc.2024.117939_b0175","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1073\/pnas.1422997112","article-title":"Structures and characterization of digoxin- and bufalin-bound Na+, K+-ATPase compared with the ouabain-bound complex","volume":"112","author":"Laursen","year":"2015","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2024.117939_b0180","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1053\/pcad.2002.31591","article-title":"Digoxin","volume":"44","author":"Eichhorn","year":"2002","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.bmc.2024.117939_b0185","first-page":"e56755","article-title":"A comprehensive review on unveiling the journey of digoxin: past, present, and future perspectives","volume":"16","author":"Khandelwal","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.bmc.2024.117939_b0190","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF00408668","article-title":"Human myocardial Na+\/K+-ATPase concentration in heart failure","volume":"163","author":"Bundgaard","year":"1996","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.bmc.2024.117939_b0195","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S0008-6363(02)00466-2","article-title":"Myocardial Na+\/K+-ATPase: the molecular basis for the hemodynamic effect of digoxin therapy in congestive heart failure","volume":"55","author":"Kjeldsen","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.bmc.2024.117939_b0200","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.3892\/etm.2014.2013","article-title":"Intermittent low-dose digoxin may be effective and safe in patients with chronic heart failure undergoing maintenance hemodialysis","volume":"8","author":"Li","year":"2014","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.bmc.2024.117939_b0205","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.amjmed.2020.05.030","article-title":"Digoxin initiation and outcomes in patients with heart failure (HFrEF and HFpEF) and atrial fibrillation","volume":"133","author":"Singh","year":"2020","journal-title":"Am J Med"},{"key":"10.1016\/j.bmc.2024.117939_b0210","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/0897190016642361","article-title":"Role of digoxin in atrial fibrillation","volume":"30","author":"Scalese","year":"2017","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.bmc.2024.117939_b0215","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11886-018-1047-y","article-title":"Is there still a role for digoxin in the management of atrial fibrillation?","volume":"20","author":"Washam","year":"2018","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.bmc.2024.117939_b0220","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.cjca.2023.07.013","article-title":"Beta-blockers and digoxin in atrial fibrillation: back to the future","volume":"39","author":"Dorian","year":"2023","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.bmc.2024.117939_b0225","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/MJT.0b013e3181c6c0d2","article-title":"Contemporary indications and therapeutic implications for digoxin use","volume":"18","author":"Mittal","year":"2011","journal-title":"Am J Ther"},{"key":"10.1016\/j.bmc.2024.117939_b0230","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.repc.2012.11.007","article-title":"Digoxin in advanced heart failure patients: a question of rhythm","volume":"32","author":"Jorge","year":"2013","journal-title":"Rev Port Cardiol"},{"key":"10.1016\/j.bmc.2024.117939_b0235","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1742-1241.2011.02771.x","article-title":"Mortality and morbidity of heart failure treated with digoxin. A propensity-matched study","volume":"65","author":"Andrey","year":"2011","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.bmc.2024.117939_b0240","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/eurheartj\/ehv143","article-title":"Digoxin-associated mortality: a systematic review and meta-analysis of the literature","volume":"36","author":"Vamos","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.bmc.2024.117939_b0245","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00228-023-03470-y","article-title":"Effect of digoxin on all-cause and cardiovascular mortality in patients with atrial fibrillation with and without heart failure: an umbrella review of systematic reviews and 12 meta-analyses","volume":"79","author":"Gazzaniga","year":"2023","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.bmc.2024.117939_b0250","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s40256-024-00639-3","article-title":"Digoxin is not related to mortality in patients with heart failure: results from the SELFIE-TR registry","volume":"24","author":"G\u00fcvenc","year":"2024","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.bmc.2024.117939_b0255","doi-asserted-by":"crossref","first-page":"18","DOI":"10.18773\/austprescr.2016.006","article-title":"Management of digoxin toxicity","volume":"39","author":"Pincus","year":"2016","journal-title":"Aust Prescr"},{"key":"10.1016\/j.bmc.2024.117939_b0260","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/jamainternmed.2023.7244","article-title":"Possible digoxin-related toxic effects in a patient","volume":"184","author":"Lee","year":"2024","journal-title":"JAMA Int Med"},{"key":"10.1016\/j.bmc.2024.117939_b0265","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tips.2022.10.002","article-title":"Digoxin as an emerging therapy in noncardiac diseases","volume":"44","author":"Dashti","year":"2023","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bmc.2024.117939_b0270","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1158\/2159-8274.CD-10-0020","article-title":"A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment","volume":"1","author":"Platz","year":"2011","journal-title":"Cancer Discov"},{"key":"10.1016\/j.bmc.2024.117939_b0275","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1021\/acs.jnatprod.9b01060","article-title":"Na+\/K+-ATPase-targeted cytotoxicity of (+)-digoxin and several semisynthetic derivatives","volume":"83","author":"Ren","year":"2020","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2024.117939_b0280","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/gastro\/goaa076","article-title":"Multifaceted anti-colorectal tumor effect of digoxin on HCT8 and SW620 cells in vitro","volume":"8","author":"Hou","year":"2020","journal-title":"Gastroenterol Rep"},{"key":"10.1016\/j.bmc.2024.117939_b0285","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/15384047.2018.1504723","article-title":"Sodium chloride (NaCl) potentiates digoxin-induced anti-tumor activity in small cell lung cancer","volume":"20","author":"Deng","year":"2019","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.bmc.2024.117939_b0290","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3389\/fphar.2020.00186","article-title":"Digoxin enhances the anticancer effect on non-small cell lung cancer while reducing the cardiotoxicity of adriamycin","volume":"11","author":"Wang","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmc.2024.117939_b0295","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1002\/jcb.26499","article-title":"Involvement of Src signaling in the synergistic effect between cisplatin and digoxin on cancer cell viability","volume":"119","author":"Pereira","year":"2018","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bmc.2024.117939_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101131","article-title":"Digoxin sensitizes gemcitabine-resistant pancreatic cancer cells to gemcitabine via inhibiting Nrf2 signaling pathway","volume":"22","author":"Zhou","year":"2019","journal-title":"Redox Biol"},{"key":"10.1016\/j.bmc.2024.117939_b0305","first-page":"148","article-title":"Cardiac glycosides increase temozolomide anticancer activity in therapy resistant glioblastoma cells","volume":"2","author":"Valluri","year":"2022","journal-title":"Int J Transl Med"},{"key":"10.1016\/j.bmc.2024.117939_b0310","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neo.2017.01.010","article-title":"Digoxin plus trametinib therapy achieves disease control in BRAF wild-type metastatic melanoma patients","volume":"19","author":"Frankel","year":"2017","journal-title":"Neoplasia"},{"key":"10.1016\/j.bmc.2024.117939_b0315","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1021\/acsptsci.3c00296","article-title":"Digoxin-mediated inhibition of potential hypoxia-related angiogenic repair in modulated electro-hyperthermia (mEHT)-treated murine triple-negative breast cancer model","volume":"7","author":"Bokhari","year":"2024","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.bmc.2024.117939_b0320","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1021\/acsami.9b19323","article-title":"Restoration and enhancement of immunogenic cell death of cisplatin by coadministration with digoxin and conjugation to HPMA copolymer","volume":"12","author":"Xiang","year":"2020","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.bmc.2024.117939_b0325","doi-asserted-by":"crossref","first-page":"7355","DOI":"10.1038\/s41598-018-25688-y","article-title":"Combination of anti-vascular agent-DMXAA and HIF-1\u03b1 inhibitor-digoxin inhibits the growth of melanoma tumors","volume":"8","author":"Smolarczyk","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2024.117939_b0330","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.3390\/molecules26123672","article-title":"Structural insights into the interactions of digoxin and Na+\/K+-ATPase and other targets for the inhibition of cancer cell proliferation","volume":"26","author":"Ren","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2024.117939_b0335","doi-asserted-by":"crossref","first-page":"15590","DOI":"10.1021\/acsomega.4c00373","article-title":"Incorporating network pharmacology and experimental validation to identify bioactive compounds and potential mechanisms of digitalis in treating anaplastic thyroid cancer","volume":"9","author":"Zhu","year":"2024","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmc.2024.117939_b0340","doi-asserted-by":"crossref","first-page":"19579","DOI":"10.1073\/pnas.0809763105","article-title":"Digoxin and other cardiac glycosides inhibit HIF-1\u03b1 synthesis and block tumor growth","volume":"105","author":"Zhang","year":"2008","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2024.117939_b0345","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4103\/2322-1232.254805","article-title":"Antitumoral effects of digoxin in the liver cancer cell line is mediated through induction of apoptosis and down regulation of HIF-\u03b1 expression","volume":"7","author":"Tahervand","year":"2018","journal-title":"J Rep Pharm Sci"},{"key":"10.1016\/j.bmc.2024.117939_b0350","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.3390\/cancers12082169","article-title":"Identification of cardiac glycosides as novel inhibitors of eIF4A1-mediated translation in triple-negative breast cancer cells","volume":"12","author":"Howard","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bmc.2024.117939_b0355","article-title":"Digoxin exerts anticancer activity on human nonsmall cell lung cancer cells by blocking PI3K\/Akt pathway","volume":"41:BSR20211056","author":"Wang","year":"2021","journal-title":"Biosci Rep"},{"key":"10.1016\/j.bmc.2024.117939_b0360","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.3390\/molecules26185675","article-title":"Interaction of (+)-strebloside and its derivatives with Na+\/K+-ATPase and other targets","volume":"26","author":"Ren","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2024.117939_b0365","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.3389\/fphar.2018.01460","article-title":"Digoxin, an overlooked agonist of ROR\u03b3\/ROR\u03b3T","volume":"9","author":"Karas","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bmc.2024.117939_b0370","doi-asserted-by":"crossref","first-page":"e0123305","DOI":"10.1371\/journal.pone.0123305","article-title":"Digoxin suppresses tumor malignancy through inhibiting multiple Src-related signaling pathways in non-small cell lung cancer","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2024.117939_b0375","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.bbrc.2020.01.154","article-title":"Downregulation of BIS sensitizes A549 cells for digoxin-mediated inhibition of invasion and migration by the STAT3-dependent pathway","volume":"524","author":"Yun","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bmc.2024.117939_b0380","doi-asserted-by":"crossref","first-page":"e0178611","DOI":"10.1371\/journal.pone.0178611","article-title":"Cardiac glycosides use and the risk and mortality of cancer; systematic review and meta-analysis of observational studies","volume":"12","author":"Osman","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2024.117939_b0385","doi-asserted-by":"crossref","first-page":"16597","DOI":"10.1038\/s41598-019-53392-y","article-title":"Integrative analysis of clinical and bioinformatics databases to identify anticancer properties of digoxin","volume":"9","author":"Yokoyama","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2024.117939_b0390","article-title":"Digoxin reduces the incidence of prostate cancer but increases the cancer-specific mortality: a systematic review and pooled analysis","volume":"53:e14217","author":"Zhao","year":"2021","journal-title":"Andrologia"},{"key":"10.1016\/j.bmc.2024.117939_b0395","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/MEJ.0000000000001065","article-title":"Diagnosis and practical management of digoxin toxicity: a narrative review and consensus","volume":"30","author":"Andrews","year":"2023","journal-title":"Eur J Emerg Med"},{"key":"10.1016\/j.bmc.2024.117939_b0400","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejmech.2017.12.086","article-title":"Synthesis of C3-neoglycosides of digoxigenin and their anticancer activities","volume":"145","author":"Li","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2024.117939_b0405","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1016\/j.bmc.2015.06.028","article-title":"\u03b3-Benzylidene digoxin derivatives synthesis and molecular modeling: evaluation of anticancer and the Na+\/K+-ATPase activity effect","volume":"23","author":"Alves","year":"2015","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2024.117939_b0410","article-title":"21-Benzylidene digoxin: a proapoptotic cardenolide of cancer cells that up-regulates Na+\/K+-ATPase and epithelial tight junctions","volume":"9:e108776","author":"Rocha","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2024.117939_b0415","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/14756366.2017.1380637","article-title":"Selectivity analyses of \u03b3-benzylidene digoxin derivatives to different Na+\/K+-ATPase \u03b1 isoforms: a molecular docking approach","volume":"33","author":"Pess\u00f4a","year":"2018","journal-title":"J Enzyme Inhibit Med Chem"},{"key":"10.1016\/j.bmc.2024.117939_b0420","first-page":"1583","article-title":"Chemical and pharmacological observation on Acokanthera schimperi","volume":"43","author":"Lewin","year":"1906","journal-title":"Berl Klin Wochenschr"},{"key":"10.1016\/j.bmc.2024.117939_b0425","first-page":"1185","article-title":"Ouabain, C29H44O12\u22c58 H2O","volume":"9","author":"Messerschmidt","year":"1980","journal-title":"Cryst Struct Commun"},{"key":"10.1016\/j.bmc.2024.117939_b0430","first-page":"1329","article-title":"Ouabain diethanol, C29H44O12\u22c52 C2H5OH","volume":"10","author":"Go","year":"1981","journal-title":"Cryst Struct Commun"},{"key":"10.1016\/j.bmc.2024.117939_b0435","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/asia.200800429","article-title":"Total synthesis of ouabagenin and ouabain","volume":"4","author":"Reddy","year":"2009","journal-title":"Chem Asian J"},{"key":"10.1016\/j.bmc.2024.117939_b0440","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1111\/j.1742-1241.2010.02395.x","article-title":"Ouabain - the insulin of the heart","volume":"64","author":"F\u00fcrstenwerth","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.bmc.2024.117939_b0445","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.3389\/fphys.2020.01060","article-title":"Ouabain-induced cell death and survival. Role of \u03b11-Na, K-ATPase-mediated signaling and Na+i\/K+i-dependent gene expression","volume":"11","author":"Lopina","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.bmc.2024.117939_b0450","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.2147\/OTT.S283548","article-title":"Ouabain exhibited strong anticancer effects in melanoma cells via induction of apoptosis, G2\/M phase arrest, and migration inhibition","volume":"14","author":"Wang","year":"2021","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.bmc.2024.117939_b0455","doi-asserted-by":"crossref","first-page":"e0287769","DOI":"10.1371\/journal.pone.0287769","article-title":"Ouabain at nanomolar concentrations is cytotoxic for biliary tract cancer cells","volume":"18","author":"Mayr","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.bmc.2024.117939_b0460","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/tox.23130","article-title":"In vitro antitumoral effects of the steroid ouabain on human thyroid papillary carcinoma cell lines","volume":"36","author":"Teixeira","year":"2021","journal-title":"Environ Toxicol"},{"key":"10.1016\/j.bmc.2024.117939_b0465","doi-asserted-by":"crossref","first-page":"6168","DOI":"10.3390\/cancers14246168","article-title":"Ouabain effects on human anaplastic thyroid carcinoma 8505C cells","volume":"14","author":"Teixeira","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.bmc.2024.117939_b0470","article-title":"A high-throughput small molecule screen identifies ouabain as synergistic with miR-34a in killing lung cancer cells","volume":"23:100878","author":"Rupaimoole","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.bmc.2024.117939_b0475","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1186\/s12964-023-01317-8","article-title":"Cardiac glycoside ouabain efficiently targets leukemic stem cell apoptotic machinery independent of cell differentiation status","volume":"21","author":"Poohadsuan","year":"2023","journal-title":"Cell Commun Signal"},{"key":"10.1016\/j.bmc.2024.117939_b0480","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1749-6632.2008.03969.x","article-title":"Modulation of the immune system by ouabain","volume":"1153","author":"Rodrigues-Mascarenhas","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bmc.2024.117939_b0485","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.21873\/anticanres.15241","article-title":"Ouabain suppresses cell migration and invasion in human gastric cancer AGS cells through the inhibition of MMP signaling pathways","volume":"41","author":"Chen","year":"2021","journal-title":"Anticancer Res"},{"key":"10.1016\/j.bmc.2024.117939_b0490","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3390\/ijms22010358","article-title":"Ouabain promotes gap junctional intercellular communication in cancer cells","volume":"22","author":"Serrano-Rubi","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2024.117939_b0495","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bmc.2024.117939_b0500","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.3390\/biomedicines11082205","article-title":"In vitro study of the multimodal effect of Na+\/K+ ATPase blocker ouabain on the tumor microenvironment and malignant cells","volume":"11","author":"Harich","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.bmc.2024.117939_b0505","first-page":"25","article-title":"Ouabain as an anticancer agent?","volume":"21","author":"Matozzo","year":"2020","journal-title":"Curr Top Biochem Res"},{"key":"10.1016\/j.bmc.2024.117939_b0510","article-title":"Ouabain and chloroquine trigger senolysis of BRAF-V600E-induced senescent cells by targeting autophagy","volume":"20:e13447","author":"L\u2032H\u00f4te","year":"2021","journal-title":"Aging Cell"},{"key":"10.1016\/j.bmc.2024.117939_b0515","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.21873\/invivo.12552","article-title":"Ouabain induces DNA damage in human osteosarcoma U-2 OS cells and alters the expression of DNA damage and DNA repair-associated proteins","volume":"35","author":"Yang","year":"2021","journal-title":"In Vivo"},{"key":"10.1016\/j.bmc.2024.117939_b0520","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41401-019-0290-0","article-title":"Ouabain impairs cancer metabolism and activates AMPK-Src signaling pathway in human cancer cell lines","volume":"41","author":"Shen","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.bmc.2024.117939_b0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2019.113741","article-title":"The cardenolides ouabain and reevesioside A promote FGF2 secretion and subsequent FGFR1 phosphorylation via converged ERK1\/2 activation","volume":"172","author":"Zhao","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bmc.2024.117939_b0530","doi-asserted-by":"crossref","first-page":"3840","DOI":"10.3390\/cancers12123840","article-title":"Ouabain and digoxin activate the proteasome and the degradation of the ER\u03b1 in cells modeling primary and metastatic breast cancer","volume":"12","author":"Busonero","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bmc.2024.117939_b0535","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.684316","article-title":"Cardiac glycoside ouabain exerts anticancer activity via downregulation of STAT3","volume":"11","author":"Du","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.bmc.2024.117939_b0540","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12576-024-00914-7","article-title":"Negative regulation of thyroid adenoma-associated protein (THADA) in the cardiac glycoside-induced anticancer effect","volume":"74","author":"Katoh","year":"2024","journal-title":"J Physiol Sci"},{"key":"10.1016\/j.bmc.2024.117939_b0545","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.toxicon.2022.06.010","article-title":"Antitumor effects of oleandrin in different types of cancers: systematic review","volume":"216","author":"Francischini","year":"2022","journal-title":"Toxicon"},{"key":"10.1016\/j.bmc.2024.117939_b0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxicon.2023.107047","article-title":"A toxic shrub turned therapeutic: the dichotomy of Nerium oleander bioactivities","volume":"224","author":"Sharma","year":"2023","journal-title":"Toxicon"},{"key":"10.1016\/j.bmc.2024.117939_b0555","first-page":"1323","article-title":"Oleandrin, C32H48O9","volume":"10","author":"Kartha","year":"1981","journal-title":"Cryst Struct Commun"},{"key":"10.1016\/j.bmc.2024.117939_b0560","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1021\/acs.orglett.2c04358","article-title":"Development of \u03b1-selective glycosylation with L-oleandral and its application to the total synthesis of oleandrin","volume":"25","author":"Carney","year":"2023","journal-title":"Org Lett"},{"key":"10.1016\/j.bmc.2024.117939_b0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111570","article-title":"Oleandrin: a bioactive phytochemical and potential cancer killer via multiple cellular signaling pathways","volume":"143","author":"Kanwal","year":"2020","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.bmc.2024.117939_b0570","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1021\/acs.jnatprod.6b01150","article-title":"(+)-Strebloside-induced cytotoxicity in ovarian cancer cells is mediated through cardiac glycoside signaling networks","volume":"80","author":"Chen","year":"2017","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2024.117939_b0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2019.115301","article-title":"Cytotoxic and non-cytotoxic cardiac glycosides isolated from the combined flowers, leaves, and twigs of Streblus asper","volume":"28","author":"Ren","year":"2020","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2024.117939_b0580","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1021\/acs.jnatprod.3c00094","article-title":"The cytotoxic cardiac glycoside (\u2212)-cryptanoside A from the stems of Cryptolepis dubia and its molecular targets","volume":"86","author":"Ren","year":"2023","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2024.117939_b0585","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1107\/S0567740880006590","article-title":"Structures of modified cardenolides. III. Digoxigenin dihydrate","volume":"B36","author":"Rohrer","year":"1980","journal-title":"Acta Cryst"},{"key":"10.1016\/j.bmc.2024.117939_b0590","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1107\/S0567740880010746","article-title":"Structure of gitoxin","volume":"B36","author":"Go","year":"1980","journal-title":"Acta Cryst"},{"key":"10.1016\/j.bmc.2024.117939_b0595","first-page":"447","article-title":"Ouabain","volume":"3","author":"Manunta","year":"2004","journal-title":"Encycl Endocr Dis"},{"key":"10.1016\/j.bmc.2024.117939_b0600","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/FTD.0b013e31816b90ff","article-title":"Mammalian cardenolides in cancer prevention and therapeutics","volume":"30","author":"Al-Ghoul","year":"2008","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.bmc.2024.117939_b0605","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.gendis.2020.01.008","article-title":"Na,K-ATPase as a target for endogenous cardiotonic steroids: what\u2032s the evidence?","volume":"8","author":"Orlov","year":"2021","journal-title":"Genes Dis"},{"key":"10.1016\/j.bmc.2024.117939_b0610","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/pr.108.000711","article-title":"Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets","volume":"61","author":"Bagrov","year":"2009","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.bmc.2024.117939_b0615","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4350965","article-title":"ROS and ROS-mediated cellular signaling","author":"Zhang","year":"2016","journal-title":"Oxidat Med Cell Longev"},{"key":"10.1016\/j.bmc.2024.117939_b0620","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/jcp.1041270202","article-title":"Cellular basis for the species differences in sensitivity to cardiac glycosides (digitalis)","volume":"127","author":"Gupta","year":"1986","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.bmc.2024.117939_b0625","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1038\/onc.2013.229","article-title":"The in vivo antitumor activity of cardiac glycosides in mice xenografted with human cancer cells is probably an experimental artifact","volume":"33","author":"Calder\u00f3n-Monta\u00f1o","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.bmc.2024.117939_b0630","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s10616-017-0078-3","article-title":"Digoxin reduces the mutagenic effects of mitomycin C in human and rodent cell lines","volume":"69","author":"de Oliveira","year":"2017","journal-title":"Cytotechnology"},{"key":"10.1016\/j.bmc.2024.117939_b0635","doi-asserted-by":"crossref","first-page":"13107","DOI":"10.1002\/jcb.28583","article-title":"Antagonistic anticancer effect of paclitaxel and digoxin combination","volume":"120","author":"Pereira","year":"2019","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.bmc.2024.117939_b0640","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1021\/acsami.2c18693","article-title":"Localized microsphere\/hydrogel for tumor immunotherapy of cardiac glycoside with minimal toxicity","volume":"15","author":"Gao","year":"2023","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.bmc.2024.117939_b0645","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1080\/14786410701218291","article-title":"Cardenolides content in wild Sardinian Digitalis purpurea L. populations","volume":"21","author":"Usai","year":"2007","journal-title":"Nat Prod Res"},{"key":"10.1016\/j.bmc.2024.117939_b0650","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/14756360410001722065","article-title":"Effects of digoxin and gitoxin on the enzymatic activity and kinetic parameters of Na+\/K+-ATPase","volume":"19","author":"Krsti\u0107","year":"2004","journal-title":"J Enzyme Inhibit Med Chem"},{"key":"10.1016\/j.bmc.2024.117939_b0655","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1021\/np050226l","article-title":"Digitoxin inhibits the growth of cancer cell lines at concentrations commonly found in cardiac patients","volume":"68","author":"L\u00f3pez-L\u00e1zaro","year":"2005","journal-title":"J Nat Prod"},{"key":"10.1016\/j.bmc.2024.117939_b0660","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1021\/acs.jnatprod.2c00036","article-title":"Discovery of anticancer agents of diverse natural origin","volume":"85","author":"Aldrich","year":"2022","journal-title":"J Nat Prod"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624003535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089624003535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T12:34:52Z","timestamp":1730378092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089624003535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":132,"alternative-id":["S0968089624003535"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117939","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Digoxin and its Na+\/K+-ATPase-targeted actions on cardiovascular diseases and cancer","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2024.117939","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117939"}}